Inicio › Cáncer de pulmón de células no pequeñas › Virginia

Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Virginia

137 estudios sobre Cáncer de pulmón de células no pequeñas buscan participantes en Virginia.

Ciudades en Virginia

Texto oficial del estudio (inglés)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Virginia Cancer Specialists, Fairfax

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 2, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07085091

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Local Institution - 0337, Richmond
Shenandoah Oncology, P.C., Winchester

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07361510

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ballad Health Cancer Care - Bristol, Bristol
Augusta Health Center for Cancer and Blood Disorders, Fishersville
Centra Alan B Pearson Regional Cancer Center, Lynchburg
y 7 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT04267848

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Site 04, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07814248

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

University of Virginia, Charlottesville
Virginia Cancer Specialists, Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07659782

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Blue Ridge Cancer Care, Christiansburg
Virginia Oncology Associates, Norfolk

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07361497

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Virgnia Cancer Specialists /ID# 269633, Leesburg

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06772623

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Virginia Cancer Specialists ( Site 0114), Fairfax

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07554339

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07127874

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Virginia Cancer Specialists, Fairfax

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06881784

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Hematology Oncology Associates of Fredericksburg Inc, Fredericksburg
Centra Alan B Pearson Regional Cancer Center, Lynchburg
Virginia Cancer Institute, Richmond
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06498635

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Hematology Oncology Associates of Fredericksburg ( Site 9550), Fredericksburg
Blue Ridge Cancer Care ( Site 0144), Roanoke

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07190248

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Virginia Cancer Specialists ( Site 0167), Fairfax
Virginia Oncology Associates (VOA) ( Site 8101), Norfolk
VCU Health Adult Outpatient Pavillion ( Site 0193), Richmond

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06623422

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care, Blacksburg
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer care| Emmett Medical & Surgical Center, Low Moor
VCU Emergency Center at New Kent, Quinton
y 12 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07144280

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Virginia Cancer Specialists, Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05498428

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Hematology Oncology Associates of Fredericksburg ( Site 3275), Fredericksburg

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07513376

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

VCU Medical Center Gateway Building, Richmond
Virginia Commonwealth University, Richmond
VCU Health Stony Point, Richmond
y 4 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07227298

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

UVA Comprehensive Cancer Center, Charlottesville
UVA Health Fontaine Research Park, Charlottesville
University of Virginia, Charlottesville
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07222566

A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer

Virginia Cancer Specialists, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07227025

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Virginia Cancer Specialists, Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06667076

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

University of Virginia Cancer Center, Charlottesville

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT03191149

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

University of Virginia Health System, Charlottesville
VCU Health Adult Outpatient Pavillion, Richmond

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06890598

Pan-tumor MRD Study

Virginia Cancer Institute, Richmond

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06605404

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Fairfax

ReclutandoFase 2

Edades de 18 a 95 · Todos los sexos · Actualizado el 23 sept 2026 · NCT05061550

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Virginia Cancer Specialists PC, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07140016

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Fort Belvoir
Research Site, Leesburg
Research Site, Midlothian
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT06357533

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

University of Virginia Health System, Charlottesville
Virginia Commonwealth University (Vcu), Richmond

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07100080

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Virginia Cancer Specialists - Arlington, Arlington
Virginia Cancer Specialists, Fairfax
VCU Massey Cancer Center, Richmond
y 1 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06712316

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Inova Schar Cancer Institute Clinical Trials, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07488676

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06568939

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Virginia Cancer Specialists, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05983432

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Next Oncology Virginia Cancer Specialist, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07629960

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Fairfax
Research Site, Fredericksburg

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT06692738

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical Study Site, Blacksburg
Clinical Study Site, Charlottesville
Clinical Study Site, Fairfax
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT06767514

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NEXT - Virginia, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07349537

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Virginia Cancer Specialists, PC, Fairfax

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07195695

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

Blue Ridge Cancer Center, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
Shenandoah Oncology P.C., Winchester

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07365319

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

Virginia Cancer Specialists, Arlington

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07566052

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.